EQT Life Sciences (formerly LSP)
Thesis
European life sciences VC, now EQT Life Sciences, backing biotech, medtech and dementia drug development globally.
Stages
GrowthSeedSeries ASeries B
Sectors
BiotechLife SciencesHealthcare/MedtechHealth and WellnessDeep Tech/Hard Science
Fund
- Current fund
- LSP 7 · 2022 · $EUR 1B+
- AUM
- $~EUR 3.5B raised across 12 funds
- Check size
- $10M – $60M